AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
CME Group:UBS lowers PT to $285, maintains Neutral rating.
ByAinvest
Monday, Sep 8, 2025 8:34 am ET1min read
CME Group:UBS lowers PT to $285, maintains Neutral rating.
UBS has recently adjusted its price target for CME Group Inc. (NASDAQ:CME), lowering it to $285 from $305, while maintaining a Neutral rating. This move comes after a series of positive developments for the company, including a strong earnings report and increased institutional ownership.CME Group reported earnings per share (EPS) of $2.96 for the quarter, exceeding the consensus estimate of $2.91. The company also saw a year-over-year revenue increase of 10.4%. Additionally, several institutional investors, including GQG Partners and Wellington Management Group, significantly increased their stakes in the company during the first quarter. This increased ownership, coupled with the positive earnings report, has likely contributed to the upward trend in the stock's price.
However, UBS's lower price target suggests a cautious stance on the company's future prospects. The investment bank may be factoring in potential risks or market volatility that could impact CME Group's performance. Despite the lower price target, UBS maintains a Neutral rating, indicating a balanced view of the company's prospects.
Institutional ownership of CME Group remains notably high at 87.75%, with several investors significantly increasing their stakes. Amundi, for instance, sold 576,014 shares, reducing its position by 26.4%. Meanwhile, GQG Partners increased its stake by 7,676.3%, now owning 2,205,041 shares. Other notable increases include Wellington Management Group (370.5%) and GAMMA Investing LLC (32,941.0%).
CME Group has also seen a series of positive analyst ratings and price targets. Piper Sandler boosted its price objective to $296, while Barclays set a target of $298.00. Despite these positive developments, UBS's lower price target suggests a cautious approach to the company's future prospects.
References:
[1] https://www.marketbeat.com/instant-alerts/filing-amundi-sells-576014-shares-of-cme-group-inc-cme-2025-09-04/
[2] https://www.marketbeat.com/instant-alerts/filing-gotham-asset-management-llc-has-2393-million-stock-position-in-cme-group-inc-cme-2025-09-05/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet